Feb. 2, 2022—Vanderbilt is set to establish an Engagement Coordinating Center for PCORnet, the National Patient-Centered Clinical Research Network.
Oct. 14, 2021—Vanderbilt's STAR Clinical Research Network has been approved for an additional $8.9 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) to support its efforts to improve health care throughout the Southeast and across the United States.
May. 20, 2021—According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.
Apr. 15, 2021—Up to 25% of patients with acute heart failure (AHF) face mortality or hospital readmission within one month after being treated in the emergency department (ED).
Nov. 5, 2020—Hydroxychloroquine (HCQ) did not significantly reduce the incidence of COVID-19 among health care workers who participated in a national study that included Vanderbilt University Medical Center.
Apr. 2, 2020—VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.
Mar. 28, 2019—Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
Dec. 20, 2018—A research team led by Vanderbilt University Medical Center’s Russell Rothman, MD, MPP, has been approved for a $7 million research funding award from the Patient-Centered Outcomes Research Institute (PCORI) to conduct a randomized, multi-center trial comparing clinic and consumer information technology approaches to promote healthy behaviors and prevent early childhood obesity.